Analyze Diet
Journal of equine veterinary science2022; 119; 104143; doi: 10.1016/j.jevs.2022.104143

Intra-articular 2.5% polyacrylamide hydrogel, a new concept in the medication of equine osteoarthritis: A review.

Abstract: Recent clinical and experimental trials have demonstrated that intra-articular 2.5% Polyacrylamide hydrogel (PAAG) is highly effective (82.5% free of lameness horses at 2 year follow-up), lasting and safe for the treatment of equine osteoarthritis (OA). Over the last decade, intra-articular 2.5% PAAG has shown to be a potent and promising drug in the medication of OA in horses, as no other single medical treatment for OA has such prolonged efficacy. Most of these studies were presenting some limitations. Preliminary observations on the mechanisms of action of intra-articular 2.5% PAAG support a mechanical effect through integration into the synovial membrane, an increase in joint elasticity possibly reducing overall joint capsule stiffness, and provision of lasting viscosupplementation which contributes to protecting articular surfaces. In addition, no effects on pro-inflammatory cytokines have been observed. Studies also suggest that these positive effects occur in the absence of intra-articular neurotoxicity or fibrosis. The effect on the synovial membrane and joint capsule and the long-acting viscosupplementation represent new concepts in the management of equine OA. Horse; Osteoarthritis, Medication, 2.5% polyacrylamide hydrogel.
Publication Date: 2022-10-20 PubMed ID: 36273533DOI: 10.1016/j.jevs.2022.104143Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article reviews the clinical and experimental application of intra-articular 2.5% Polyacrylamide hydrogel (PAAG) in managing and treating equine osteoarthritis (OA). The research has found it to be promising, effective, and safe, with long-lasting effects and no obvious negative impacts.

Overview of the Research

  • The article presents a comprehensive review of the recent clinical and experimental trials investigating the use of intra-articular 2.5% PAAG as a treatment for equine OA.
  • It was found that this treatment is extremely effective, with 82.5% of horses being free of lameness two years after receiving treatment.
  • The review recognizes that PAAG is a potent and promising drug in the ongoing medication of equine OA, given its prolonged efficacy. This is particularly notable, as no other single OA treatment has exhibited such an extended period of effectiveness.

Limitations of the Studies

  • Despite the positive findings, the article notes that some of the studies reviewed were limited in their scope, which may have influenced their outcomes.

Mechanism of Action

  • The mechanism of action of intra-articular 2.5% PAAG is primarily through its integration into the synovial membrane, which is the soft tissue that lines the spaces of diarthrodial joints, tendon sheaths, and bursae. This integration results in increased joint elasticity, possibly decreasing overall joint capsule stiffness.
  • Additionally, PAAG provides lasting viscosupplementation, which serves to protect the articular surfaces of the joints. This is a new concept in managing equine OA.

Side Effects

  • The review also reports that use of intra-articular 2.5% PAAG has not shown effects on pro-inflammatory cytokines, substances secreted by certain cells of the immune system which have an effect on other cells.
  • Furthermore, positive treatment outcomes were achieved without causing intra-articular neurotoxicity or fibrosis, an important consideration in sustaining the health of the horses.

Cite This Article

APA
Tnibar A. (2022). Intra-articular 2.5% polyacrylamide hydrogel, a new concept in the medication of equine osteoarthritis: A review. J Equine Vet Sci, 119, 104143. https://doi.org/10.1016/j.jevs.2022.104143

Publication

ISSN: 0737-0806
NlmUniqueID: 8216840
Country: United States
Language: English
Volume: 119
Pages: 104143
PII: S0737-0806(22)00279-9

Researcher Affiliations

Tnibar, Aziz
  • The Equine Hospital, Jockey Club of Saudi Arabia, PO Box 26323, Riyadh, Saudi Arabia. Electronic address: aztnibar@gmail.com.

MeSH Terms

  • Horses
  • Animals
  • Injections, Intra-Articular / veterinary
  • Osteoarthritis / drug therapy
  • Osteoarthritis / veterinary
  • Viscosupplementation / veterinary
  • Synovial Membrane
  • Horse Diseases / drug therapy

Citations

This article has been cited 0 times.